cytarabine has been researched along with lipoteichoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bal-Price, A; Brown, GC; Coecke, S; Deininger, S; Hartung, T; Kinsner, A; Pilotto, V | 1 |
1 other study(ies) available for cytarabine and lipoteichoic acid
| Article | Year |
|---|---|
Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Analysis of Variance; Animals; Animals, Newborn; Caspases; Cell Death; Cell Proliferation; Cells, Cultured; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Encephalitis; Enzyme Activation; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Interleukin-1; Interleukin-6; Lectins; Lipopolysaccharides; Models, Biological; Neurodegenerative Diseases; Neuroglia; Nitrites; Oxidative Stress; Rats; Receptors, Interleukin-1; Staphylococcus aureus; Teichoic Acids; Time Factors; Tumor Necrosis Factor-alpha | 2005 |